Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

ONO-6950

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Although the effectiveness of CysLT1 receptor antagonists on asthma has been clinically established, the effects of CysLT2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
The cysteinyl leukotrienes (cysLTs) play a key role in the pathophysiology of asthma. In addition to functioning as potent… Expand
2015
2015
An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and… Expand
2015
2015
We assessed in this study the anti-asthmatic effects of ONO-6950, a novel cysteinyl leukotriene 1 (CysLT1) and 2 (CysLT2… Expand
  • table 1
2015
2015
BACKGROUND The expression and functional role of CysLT2 receptors in asthma have not been clarified. In this study, we evaluated… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2014
2014
Background: The cysteinyl leukotrienes (CysLTs) play a key role in the pathophysiology of asthma. In addition to functioning as… Expand